Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The daily Top 10 COVID papers

Breast Cancer

Free Subscription 07.12.2020 2 Ann Surg Oncol 2 BMC Cancer 1 BMJ 5 Br J Cancer 7 Breast Cancer Res 3 Breast Cancer Res Treat 14 Breast J 2 Cancer 1 Cancer Epidemiol Biomarkers Prev 1 Cancer Lett 2 Cancer Res 2 Clin Breast Cancer 2 Clin Cancer Res 1 Clin Exp Metastasis 3 Eur J Surg Oncol 3 Eur Radiol 1 Histopathology 2 Int J Cancer 1 Int J Radiat Oncol Biol Phys 2 J Nucl Med 2 Lancet Oncol 1 Nature 3 Oncogene 5 PLoS One 1 Radiology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. VAN LOEVEZIJN AA, van der Noordaa MEM, van Werkhoven ED, Loo CE, et al
   Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study.
   Ann Surg Oncol. 2020 Dec 2. pii: 10.1245/s10434-020-09273.
   PubMed         Abstract available
   
   
2. SHAMS S, Lippold K, Blohmer JU, Rohle R, et al
   A Pilot Study Evaluating the Effects of Magtrace(R) for Sentinel Node Biopsy in Breast Cancer Patients Regarding Care Process Optimization, Reimbursement, Surgical Time, and Patient Comfort Compared With Standard Technetium(99).
   Ann Surg Oncol. 2020 Dec 1. pii: 10.1245/s10434-020-09280.
   PubMed         Abstract available
   
   

   
   BMC Cancer

3. TORRES-ROMAN JS, Martinez-Herrera JF, Carioli G, Ybaseta-Medina J, et al
   Breast cancer mortality trends in Peruvian women.
   BMC Cancer. 2020;20:1173.
   PubMed         Abstract available
   
   
4. KROZ M, Reif M, Glinz A, Berger B, et al
   Correction to: Impact of a combined multimodal-aerobic and multimodal intervention compared to standard aerobic treatment in breast cancer survivors with chronic cancer-related fatigue - results of a three-armed pragmatic trial in a comprehensive coho
   BMC Cancer. 2020;20:1174.
   PubMed         Abstract available
   
   

   
   BMJ

5. DODWELL D, Jauhari Y, Gathani T, Cromwell D, et al
   Treatment variation in early breast cancer in the UK.
   BMJ. 2020;371:m4237.
   PubMed        
   
   

   
   Br J Cancer

6. GATHANI T, Clayton G, MacInnes E, Horgan K, et al
   The COVID-19 pandemic and impact on breast cancer diagnoses: what happened in England in the first half of 2020.
   Br J Cancer. 2020 Nov 30. pii: 10.1038/s41416-020-01182.
   PubMed         Abstract available
   
   
7. BAILLEUX C, Eberst L, Bachelot T
   Treatment strategies for breast cancer brain metastases.
   Br J Cancer. 2020 Nov 30. pii: 10.1038/s41416-020-01175.
   PubMed         Abstract available
   
   
8. DUSTIN D, Gu G, Beyer AR, Herzog SK, et al
   RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer.
   Br J Cancer. 2020 Dec 1. pii: 10.1038/s41416-020-01174.
   PubMed         Abstract available
   
   
9. ROLVER MG, Pedersen SF
   Putting Warburg to work: how imaging of tumour acidosis could help predict metastatic potential in breast cancer.
   Br J Cancer. 2020 Dec 1. pii: 10.1038/s41416-020-01171.
   PubMed         Abstract available
   
   
10. ANEMONE A, Consolino L, Conti L, Irrera P, et al
    Tumour acidosis evaluated in vivo by MRI-CEST pH imaging reveals breast cancer metastatic potential.
    Br J Cancer. 2020 Dec 1. pii: 10.1038/s41416-020-01173.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res

11. LEONE JP, Emblem KE, Weitz M, Gelman RS, et al
    Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases.
    Breast Cancer Res. 2020;22:131.
    PubMed         Abstract available
    
    
12. ZOELLER JJ, Vagodny A, Daniels VW, Taneja K, et al
    Navitoclax enhances the effectiveness of EGFR-targeted antibody-drug conjugates in PDX models of EGFR-expressing triple-negative breast cancer.
    Breast Cancer Res. 2020;22:132.
    PubMed         Abstract available
    
    
13. WAFAI R, Williams ED, de Souza E, Simpson PT, et al
    Integrin alpha-2 and beta-1 expression increases through multiple generations of the EDW01 patient-derived xenograft model of breast cancer-insight into their role in epithelial mesenchymal transition in vivo gained from an in vitro model system.
    Breast Cancer Res. 2020;22:136.
    PubMed         Abstract available
    
    
14. GHALEB A, Padellan M, Marchenko N
    Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells.
    Breast Cancer Res. 2020;22:133.
    PubMed         Abstract available
    
    
15. FERNANDEZ SV, MacFarlane AW 4th, Jillab M, Arisi MF, et al
    Immune phenotype of patients with stage IV metastatic inflammatory breast cancer.
    Breast Cancer Res. 2020;22:134.
    PubMed         Abstract available
    
    
16. FREDOLINI C, Pathak KV, Paris L, Chapple KM, et al
    Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection.
    Breast Cancer Res. 2020;22:135.
    PubMed         Abstract available
    
    
17. ALHAREERI AA, Archer KJ, Fu H, Lyon DE, et al
    Telomere lengths in women treated for breast cancer show associations with chemotherapy, pain symptoms, and cognitive domain measures: a longitudinal study.
    Breast Cancer Res. 2020;22:137.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res Treat

18. SCHIZA A, Mauri D, Fredriksson I, Anna-Karin Wennstig, et al
    Predictive role of HER2-status on the effectiveness of endocrine adjuvant treatment in postmenopausal breast cancer patients: a population-based cohort study.
    Breast Cancer Res Treat. 2020 Nov 30. pii: 10.1007/s10549-020-06022.
    PubMed         Abstract available
    
    
19. BERNSTEIN-MOLHO R, Friedman E, Kedar I, Laitman Y, et al
    Diagnostic yield of multigene panel testing in an Israeli cohort: enrichment of low-penetrance variants.
    Breast Cancer Res Treat. 2020;181:445-453.
    PubMed         Abstract available
    
    
20. NOORDMAN PCW, Klioueva NM, Weimann MN, Borgstein PJ, et al
    Phyllodes tumors of the breast: a retrospective analysis of 57 cases.
    Breast Cancer Res Treat. 2020;181:361-367.
    PubMed         Abstract available
    
    

    
    Breast J

21. GUVEN DC, Sahin TK, Aksoy S
    The use of CDK 4/6 inhibitors in the adjuvant treatment of breast cancer: Timing matters.
    Breast J. 2020 Dec 4. doi: 10.1111/tbj.14126.
    PubMed        
    
    
22. MA SJ, Oladeru OT, Farrugia M, Mikucki M, et al
    Survival outcome of adjuvant chemotherapy and high 21-gene recurrence score in early-stage breast cancer.
    Breast J. 2020 Dec 3. doi: 10.1111/tbj.14130.
    PubMed         Abstract available
    
    
23. NGUYEN ML, Pius P, Dooley W, Squires R, et al
    A prospective single-institution study of intraoperative radiotherapy (IORT) for early-stage breast cancer.
    Breast J. 2020 Dec 3. doi: 10.1111/tbj.14128.
    PubMed         Abstract available
    
    
24. MASUDA T, Nonami A, Tanaka F, Ando Y, et al
    A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated alphabeta T-cell immunotherapy in advanced breast cancer.
    Breast J. 2020 Dec 5. doi: 10.1111/tbj.14108.
    PubMed        
    
    
25. PAWASKAR RS, MacMillan F, Ong A, McBride K, et al
    Culture and breast cancer surgical decisions and experiences.
    Breast J. 2020 Dec 5. doi: 10.1111/tbj.14114.
    PubMed        
    
    
26. BEAULIEU-JONES BR, Ring N, Frazee TE, DiFlorio-Alexander RM, et al
    Screening vs staging magnetic resonance imaging-guided core needle breast biopsies: Does MRI indication impact upgrade rate?
    Breast J. 2020;26:216-219.
    PubMed         Abstract available
    
    
27. THULER LCS, de Aguiar SS, Rapozo D, Bello MA, et al
    Characteristics and prognosis of male breast cancer in Brazil: A cohort study.
    Breast J. 2020 Dec 1. doi: 10.1111/tbj.14120.
    PubMed        
    
    
28. KHOURY T, Fang Y, Karabakhtsian R, Mokhtar Desouki M, et al
    The clinical significance of metastatic breast carcinoma to intramammary lymph node.
    Breast J. 2020;26:197-205.
    PubMed         Abstract available
    
    
29. SHIN K, Weaver O, Wei W, Caudle AS, et al
    Sonographic features of benign and malignant axillary nodes post-neoadjuvant chemotherapy.
    Breast J. 2020;26:182-187.
    PubMed         Abstract available
    
    
30. TARIQ MU, Idress R, Qureshi MB, Kayani N, et al
    Solid papillary carcinoma of breast; a detailed clinicopathological study of 65 cases of an uncommon breast neoplasm with literature review.
    Breast J. 2020;26:211-215.
    PubMed         Abstract available
    
    
31. LIBERALE V, Rosso R, Arisio R, D'Alonzo M, et al
    Axillary dissection in patients with preoperative positive nodal cytology: Genuine need or overtreatment?
    Breast J. 2020;26:168-175.
    PubMed         Abstract available
    
    
32. BOCHENEK-CIBOR J, Georgiew F, Goyal S
    A retrospective analysis on safety and effectiveness of hypofractioned post-mastectomy radiotherapy.
    Breast J. 2020;26:176-181.
    PubMed         Abstract available
    
    
33. ALI MLEES M
    Diagnosis and surgical treatment of pathologic nipple discharge using ultrasound-guided wire localization of focal ductal dilatation.
    Breast J. 2020;26:139-143.
    PubMed         Abstract available
    
    
34. SHAH C, Obi E, Tom MC, Manyam BV, et al
    Initial outcomes with image-guided partial breast irradiation delivered with intensity-modulated radiation therapy.
    Breast J. 2020;26:227-230.
    PubMed         Abstract available
    
    

    
    Cancer

35. POORVU PD, Gelber SI, Zheng Y, Ruddy KJ, et al
    Pregnancy after breast cancer: Results from a prospective cohort of young women with breast cancer.
    Cancer. 2020 Dec 1. doi: 10.1002/cncr.33342.
    PubMed         Abstract available
    
    
36. MOHL A, Orban E, Jung AY, Behrens S, et al
    Comorbidity burden in long-term breast cancer survivors compared with a cohort of population-based controls from the MARIE study.
    Cancer. 2020 Dec 1. doi: 10.1002/cncr.33363.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

37. HINCHLIFFE A, Kogevinas M, Perez-Gomez B, Ardanaz E, et al
    Occupational Heat Exposure and Breast Cancer Risk in the MCC-Spain Study.
    Cancer Epidemiol Biomarkers Prev. 2020 Dec 2. pii: 1055-9965.EPI-20-0732.
    PubMed         Abstract available
    
    

    
    Cancer Lett

38. KIM SJ, Saeidi S, Cho NC, Kim SH, et al
    Interaction of Nrf2 with dimeric STAT3 induces IL-23 expression: Implications for breast cancer progression.
    Cancer Lett. 2020 Dec 2. pii: S0304-3835(20)30645.
    PubMed         Abstract available
    
    

    
    Cancer Res

39. FALVO P, Orecchioni S, Hillje R, Raveane A, et al
    Cyclophosphamide and vinorelbine activate stem-like CD8+ T cells and improve anti-PD-1 efficacy in triple-negative breast cancer.
    Cancer Res. 2020 Dec 2. pii: 0008-5472.CAN-20-1818.
    PubMed         Abstract available
    
    
40. WANG F, Zheng W, Bailey CE, Mayer IA, et al
    Racial/Ethnic Disparities in All-Cause Mortality Among Patients Diagnosed with Triple-Negative Breast Cancer.
    Cancer Res. 2020 Dec 3. pii: 0008-5472.CAN-20-3094.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

41. HAN Y, Wang J, Sun Y, Yu P, et al
    Prognostic Model and Nomogram for Estimating Survival of Small Breast Cancer: A SEER-based Analysis.
    Clin Breast Cancer. 2020 Nov 13. pii: S1526-8209(20)30290.
    PubMed         Abstract available
    
    
42. MANLEY H, Mutasa S, Chang P, Desperito E, et al
    Dynamic Changes of Convolutional Neural Network-based Mammographic Breast Cancer Risk Score Among Women Undergoing Chemoprevention Treatment.
    Clin Breast Cancer. 2020 Nov 17. pii: S1526-8209(20)30291.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

43. BHATIA S, Palomares MR, Hageman L, Chen Y, et al
    A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at risk for Breast Cancer.
    Clin Cancer Res. 2020 Dec 3. pii: 1078-0432.CCR-20-3609.
    PubMed         Abstract available
    
    
44. KEENAN TE, Li T, Vallius T, Guerriero JL, et al
    Clinical efficacy and molecular response correlates of the WEE1 inhibitor adavosertib combined with cisplatin in patients with metastatic triple-negative breast cancer (mTNBC).
    Clin Cancer Res. 2020 Nov 30. pii: 1078-0432.CCR-20-3089.
    PubMed         Abstract available
    
    

    
    Clin Exp Metastasis

45. COTARELO CL, Zschock-Manus A, Schmidt M, Schad A, et al
    Improved detection of sentinel lymph node metastases allows reliable intraoperative identification of patients with extended axillary lymph node involvement in early breast cancer.
    Clin Exp Metastasis. 2020 Nov 29. pii: 10.1007/s10585-020-10065.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

46. JAUHARI Y, Dodwell D, Gannon MR, Horgan K, et al
    The influence of age, comorbidity and frailty on treatment with surgery and systemic therapy in older women with operable triple negative breast cancer (TNBC) in England: A population-based cohort study.
    Eur J Surg Oncol. 2020 Oct 2. pii: S0748-7983(20)30794.
    PubMed         Abstract available
    
    
47. PEARCE BCS, Fiddes RN, Paramanathan N, Chand N, et al
    Reply to: Evidence-based surgery to realize a successful extreme oncoplastic breast conservation.
    Eur J Surg Oncol. 2020;46:926-927.
    PubMed        
    
    
48. FRANCESCHINI G, Masetti R
    Evidence-based surgery to realize a successful extreme oncoplastic breast conservation.
    Eur J Surg Oncol. 2020;46:924-925.
    PubMed        
    
    

    
    Eur Radiol

49. BERTANI V, Urbani M, La Grassa M, Balestreri L, et al
    Atypical ductal hyperplasia: breast DCE-MRI can be used to reduce unnecessary open surgical excision.
    Eur Radiol. 2020;30:4069-4081.
    PubMed         Abstract available
    
    
50. SHIN SU, Cho N, Kim SY, Lee SH, et al
    Time-to-enhancement at ultrafast breast DCE-MRI: potential imaging biomarker of tumour aggressiveness.
    Eur Radiol. 2020;30:4058-4068.
    PubMed         Abstract available
    
    
51. CHEUNG SM, Husain E, Mallikourti V, Masannat Y, et al
    Intra-tumoural lipid composition and lymphovascular invasion in breast cancer via non-invasive magnetic resonance spectroscopy.
    Eur Radiol. 2020 Dec 3. pii: 10.1007/s00330-020-07502.
    PubMed         Abstract available
    
    

    
    Histopathology

52. AKASHI M, Yamaguchi R, Kusano H, Obara H, et al
    Diverse histomorphology of HER2-positive breast carcinomas based on differential ER expression.
    Histopathology. 2020;76:560-571.
    PubMed         Abstract available
    
    

    
    Int J Cancer

53. VAN DER MEER DJ, Kramer I, van Maaren MC, van Diest PJ, et al
    Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989-2017.
    Int J Cancer. 2020 Nov 30. doi: 10.1002/ijc.33417.
    PubMed         Abstract available
    
    
54. WHITE AJ, Gregoire AM, Taylor KW, Eberle C, et al
    Adolescent use of hair dyes, straighteners and perms in relation to breast cancer risk.
    Int J Cancer. 2020 Nov 30. doi: 10.1002/ijc.33413.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

55. BERNSTEIN-MOLHO R, Laitman Y, Galper S, Jacobson G, et al
    Locoregional treatments and ipsilateral breast cancer recurrence rates in BRCA1/2 mutation carriers.
    Int J Radiat Oncol Biol Phys. 2020 Nov 28. pii: S0360-3016(20)34598.
    PubMed         Abstract available
    
    

    
    J Nucl Med

56. VISWANATH V, Zhou R, Lee H, Li S, et al
    Kinetic Modeling of (18)F-(2S,4R)4-Fluoroglutamine in Mouse Models of Breast Cancer to Estimate Glutamine Pool Size as an Indicator of Tumor Glutamine Metabolism.
    J Nucl Med. 2020 Dec 4. pii: jnumed.120.250977. doi: 10.2967/jnumed.120.250977.
    PubMed         Abstract available
    
    
57. D'HUYVETTER M, De Vos J, Caveliers V, Vaneycken I, et al
    Phase I trial of (131)I-GMIB-Anti-HER2-VHH1, a new promising candidate for HER2-targeted radionuclide therapy in breast cancer patients.
    J Nucl Med. 2020 Dec 4. pii: jnumed.120.255679. doi: 10.2967/jnumed.120.255679.
    PubMed         Abstract available
    
    

    
    Lancet Oncol

58. CROZIER JA, Pezzi TA, Hodge C, Janeva S, et al
    Addition of chemotherapy to local therapy in women aged 70 years or older with triple-negative breast cancer: a propensity-matched analysis.
    Lancet Oncol. 2020;21:1611-1619.
    PubMed         Abstract available
    
    
59. CURIGLIANO G, Pravettoni G
    Use of chemotherapy in elderly patients with early-stage triple-negative breast cancer.
    Lancet Oncol. 2020;21:1543-1545.
    PubMed        
    
    

    
    Nature

60. CAFFA I, Spagnolo V, Vernieri C, Valdemarin F, et al
    Author Correction: Fasting-mimicking diet and hormone therapy induce breast cancer regression.
    Nature. 2020 Dec 4. pii: 10.1038/s41586-020-2957.
    PubMed         Abstract available
    
    

    
    Oncogene

61. SONG Y, Zeng S, Zheng G, Chen D, et al
    FOXO3a-driven miRNA signatures suppresses VEGF-A/NRP1 signaling and breast cancer metastasis.
    Oncogene. 2020 Dec 1. pii: 10.1038/s41388-020-01562.
    PubMed         Abstract available
    
    
62. HAN J, Qu H, Han M, Ding Y, et al
    MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer.
    Oncogene. 2020 Dec 3. pii: 10.1038/s41388-020-01574.
    PubMed         Abstract available
    
    
63. FRANCART ME, Vanwynsberghe AM, Lambert J, Bourcy M, et al
    Vimentin prevents a miR-dependent negative regulation of tissue factor mRNA during epithelial-mesenchymal transitions and facilitates early metastasis.
    Oncogene. 2020;39:3680-3692.
    PubMed         Abstract available
    
    

    
    PLoS One

64. TESFAW A, Alebachew W, Tiruneh M
    Why women with breast cancer presented late to health care facility in North-west Ethiopia? A qualitative study.
    PLoS One. 2020;15:e0243551.
    PubMed         Abstract available
    
    
65. CARTER KJ, Castro F, Morcos RN
    A method for evaluating breast cancer screening strategies using screen-preventable loss of life.
    PLoS One. 2020;15:e0243113.
    PubMed         Abstract available
    
    
66. ZOU Y, Fineberg S, Pearlman A, Feinman RD, et al
    The effect of a ketogenic diet and synergy with rapamycin in a mouse model of breast cancer.
    PLoS One. 2020;15:e0233662.
    PubMed         Abstract available
    
    
67. DE MEULENAERE V, Descamps B, De Wever O, Vanhove C, et al
    In vivo selection of the MDA-MB-231br/eGFP cancer cell line to obtain a clinically relevant rat model for triple negative breast cancer brain metastasis.
    PLoS One. 2020;15:e0243156.
    PubMed         Abstract available
    
    
68. FADDA M, Chappuis PO, Katapodi MC, Pagani O, et al
    Physicians communicating with women at genetic risk of breast and ovarian cancer: Are we in the middle of the ford between contradictory messages and unshared decision making?
    PLoS One. 2020;15:e0240054.
    PubMed         Abstract available
    
    

    
    Radiology

69. DURAND MA, Friedewald SM, Plecha DM, Copit DS, et al
    False-Negative Rates of Breast Cancer Screening with and without Digital Breast Tomosynthesis.
    Radiology. 2020 Dec 1:202858. doi: 10.1148/radiol.2020202858.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: